These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 4093536)

  • 21. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
    Gandolfi SA; Vecchi M
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual field changes after transient elevation of intraocular pressure in eyes with and without glaucoma.
    Chan KC; Poostchi A; Wong T; Insull EA; Sachdev N; Wells AP
    Ophthalmology; 2008 Apr; 115(4):667-72. PubMed ID: 17716733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evolution of secondary pseudoexfoliative glaucoma after cataract surgery in patients with cataract-glaucoma combination].
    Stefan C; Nenciu A; Tebeanu E; Malcea C
    Oftalmologia; 2006; 50(1):99-102. PubMed ID: 16773948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual field progression in glaucoma: total versus pattern deviation analyses.
    Artes PH; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical glaucoma therapy as a risk factor for nasolacrimal duct obstruction.
    Seider N; Miller B; Beiran I
    Am J Ophthalmol; 2008 Jan; 145(1):120-123. PubMed ID: 17915187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Increase in visual field defects under long-term timolol treatment in patients with open-angle glaucoma - observations from an ophthalmology practice].
    Demmler N; Müller-Bardorff G
    Klin Monbl Augenheilkd; 1983 Jul; 183(1):53-8. PubMed ID: 6411963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients.
    Tomita G; Araie M; Kitazawa Y; Tsukahara S
    Eye (Lond); 2004 Oct; 18(10):984-9. PubMed ID: 15037889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical comparison of pascal dynamic contour tonometry and goldmann applanation tonometry in asymmetric open-angle glaucoma.
    Sullivan-Mee M; Halverson KD; Qualls C
    J Glaucoma; 2007 Dec; 16(8):694-9. PubMed ID: 18091457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Keratometry, optic disc dimensions, and degree and progression of glaucomatous optic nerve damage.
    Jonas JB; Stroux A; Martus P; Budde W
    J Glaucoma; 2006 Jun; 15(3):206-12. PubMed ID: 16778642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of the effectiveness of beta-blockers for intraocular pressure and visual field in primary open-angle glaucoma].
    Dobre X
    Oftalmologia; 2008; 52(4):95-9. PubMed ID: 19354170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dynamics of visual function in glaucoma patients treated with various antiglaucoma preparations].
    Zhaboedov GD; Slavnova AV; Fedirko PA
    Oftalmol Zh; 1989; (2):69-72. PubMed ID: 2755662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timolol maleate in the treatment of glaucoma simplex and glaucoma capsulare. A three-year follow up study.
    Blika S; Saunte E
    Acta Ophthalmol (Copenh); 1982 Dec; 60(6):967-76. PubMed ID: 7170939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computerized perimetric monitoring and study of scotomatous fluctuations in timolol-treated open-angle glaucoma patients.
    Pecori-Giraldi J
    Surv Ophthalmol; 1989 Apr; 33 Suppl():423-5; discussion 435-6. PubMed ID: 2749511
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of glaucoma in the implanted patient.
    Obstbaum SA
    J Am Intraocul Implant Soc; 1981; 7(3):252-9. PubMed ID: 7287569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Timolol: adverse cardiorespiratory effects].
    Domingo Regany E; Quilis Salcedo M; Massagué Camins C
    Aten Primaria; 1989 May; 6(5):362. PubMed ID: 2491593
    [No Abstract]   [Full Text] [Related]  

  • 38. Glaucoma blindness in African Americans: have 55 years of therapies, technologies, and talent altered blindness rates?
    Merritt JC
    J Natl Med Assoc; 1996 Dec; 88(12):809-19. PubMed ID: 8990808
    [No Abstract]   [Full Text] [Related]  

  • 39. Vasoconstrictive effect of topical timolol on human retinal arteries.
    Martin XD; Rabineau PA
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(6):526-30. PubMed ID: 2625208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of timolol on visual-field mean retinal sensitivity in normal subjects.
    Martin XD; Fankhauser F; Rabineau PA
    Int Ophthalmol; 1992 Sep; 16(4-5):325-9. PubMed ID: 1428567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.